Lemaitre Vascular (LMAT) Other Non-Current Assets (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Other Non-Current Assets came in at $5.4 million in Q2 2026, up 7.92% year-over-year from $5.0 million in Q2 2025, and up 9.46% quarter-over-quarter from $5.0 million in Q1 2026.
Analysis
Lemaitre Vascular (LMAT) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Other Non-Current Assets for 17 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets rose 7.92% year-over-year to $5.4 million in Q2 2026; TTM through Jun 2026 was $5.4 million, a 7.92% increase from a year earlier, with the FY2025 full-year figure at $4.9 million, up 0.78% from the prior year.
- Other Non-Current Assets was $5.4 million for Q2 2026 at Lemaitre Vascular, up from $5.0 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $5.4 million in Q2 2026 and troughed at $556000.0 in Q1 2022.
- A 5-year average of $3.5 million and a median of $4.1 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets sank 49.91% in 2022 and jumped 277.4% in 2023, its largest moves.
- Over 5 years, Other Non-Current Assets stood at $991000.0 in 2022, then jumped by 277.4% to $3.7 million in 2023, then surged by 30.16% to $4.9 million in 2024, then rose by 0.78% to $4.9 million in 2025, then climbed by 10.88% to $5.4 million in 2026.
- The last three Other Non-Current Assets figures came in at $5.4 million (Q2 2026), $5.0 million (Q1 2026), and $4.9 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 4.32 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 3.23 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 45.22 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 616.40 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 434.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 273.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 5.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.44 Mn |
| Mar 31, 2026 | 4.97 Mn |
| Dec 31, 2025 | 4.91 Mn |
| Sep 30, 2025 | 5.03 Mn |
| Jun 30, 2025 | 5.04 Mn |
| Mar 31, 2025 | 5.17 Mn |
| Dec 31, 2024 | 4.87 Mn |
| Sep 30, 2024 | 4.23 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 3.74 Mn |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | 2.93 Mn |
| Mar 31, 2023 | 2.07 Mn |
| Dec 31, 2022 | 991,000.00 |
| Sep 30, 2022 | 973,000.00 |
| Jun 30, 2022 | 984,000.00 |
| Mar 31, 2022 | 556,000.00 |
| Dec 31, 2021 | 568,000.00 |
| Sep 30, 2021 | 994,000.00 |